{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:08:07Z","timestamp":1789153687551,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Recurrent implantation failure (RIF) brings great challenges to clinicians and causes deep frustration to patients. Previous data has suggested that prednisone may play a promising role in the establishment of pregnancy and help improve the pregnancy outcome in women with RIF. But there is insufficient evidence from randomized clinical trials that had adequate power to determine if prednisone can enhance live births as the primary outcome.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods\/design<\/jats:title>\n<jats:p>This trial is a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial (1:1 ratio of prednisone versus placebo). Infertile patients with RIF who intend to undergo frozen-thawed embryo transfer (FET) after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) or pre-implantation genetic testing for aneuploidy (PGT-A) will be enrolled and randomly assigned to two parallel groups. Participants will be given the treatment of prednisone or placebo from the start of endometrial preparation till the end of the first trimester of pregnancy if pregnant. The primary outcome is live birth rate.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>The results of this study will provide evidence for the effect of prednisone on pregnancy outcomes in patients with RIF.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>Chinese Clinical Trial Registry, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/edit.aspx?pid=31155&amp;htm=4\">ChiCTR1800018783<\/jats:ext-link>. Registered on 9 October 2018.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13063-020-04630-6","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T10:03:15Z","timestamp":1597658595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prednisone for patients with recurrent implantation failure: study protocol for a double-blind, multicenter, randomized, placebo-controlled trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Yao","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daimin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-jiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9073-8142","authenticated-orcid":false,"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"4630_CR1","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.biopha.2016.10.062","volume":"84","author":"S Abdolmohammadi-Vahid","year":"2016","unstructured":"Abdolmohammadi-Vahid S, Danaii S, Hamdi K, Jadidi-Niaragh F, Ahmadi M, Yousefi M. Novel immunotherapeutic approaches for treatment of infertility. Biomed Pharmacother. 2016;84:1449\u201359.","journal-title":"Biomed Pharmacother"},{"key":"4630_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.rbmo.2013.08.011","volume":"28","author":"C Coughlan","year":"2014","unstructured":"Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod BioMed Online. 2014;28:14\u201338.","journal-title":"Reprod BioMed Online"},{"key":"4630_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijgo.2013.08.006","volume":"124","author":"C Coughlan","year":"2014","unstructured":"Coughlan C, Walters S, Ledger W, Li TC. A comparison of psychological stress among women with and without reproductive failure. Int J Gynaecol Obstet. 2014;124:143\u20137.","journal-title":"Int J Gynaecol Obstet"},{"key":"4630_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.rbmo.2013.12.006","volume":"28","author":"LT Polanski","year":"2014","unstructured":"Polanski LT, Baumgarten MN, Quenby S, Brosens J, Campbell BK, Raine-Fenning NJ. What exactly do we mean by \u2018recurrent implantation failure\u2019? A systematic review and opinion. Reprod BioMed Online. 2014;28:409\u201323.","journal-title":"Reprod BioMed Online"},{"key":"4630_CR5","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.fertnstert.2017.04.009","volume":"107","author":"MM Hviid","year":"2017","unstructured":"Hviid MM, Macklon N. Immune modulation treatments-where is the evidence? Fertil Steril. 2017;107:1284\u201393.","journal-title":"Fertil Steril"},{"key":"4630_CR6","doi-asserted-by":"crossref","unstructured":"Benschop L, Seshadri S, Toulis KA, Vincent K, Child T, Granne IE, et al. Immune therapies for women with history of failed implantation undergoing IVF treatment. Cochrane Database Syst Rev. 2012; http:\/\/cochranelibrary-wiley.com\/doi\/10.1002\/14651858.CD009602\/abstract.","DOI":"10.1002\/14651858.CD009602"},{"key":"4630_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000323500","volume":"133","author":"E Fragouli","year":"2011","unstructured":"Fragouli E, Wells D. Aneuploidy in the human blastocyst. Cytogenet Genome Res. 2011;133:149\u201359.","journal-title":"Cytogenet Genome Res"},{"key":"4630_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-0034-1375182","volume":"32","author":"HB Zeyneloglu","year":"2014","unstructured":"Zeyneloglu HB, Onalan G. Remedies for recurrent implantation failure. Semin Reprod Med. 2014;32:297\u2013305.","journal-title":"Semin Reprod Med"},{"key":"4630_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/humupd\/dmq037","volume":"17","author":"H Cakmak","year":"2011","unstructured":"Cakmak H, Taylor HS. Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update. 2011;17:242\u201353.","journal-title":"Hum Reprod Update"},{"key":"4630_CR10","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1093\/humrep\/dew186","volume":"31","author":"SA Robertson","year":"2016","unstructured":"Robertson SA, Jin M, Yu D, Moldenhauer LM, Davies MJ, Hull ML, et al. Corticosteroid therapy in assisted reproduction - immune suppression is a faulty premise. Hum Reprod (Oxford, England). 2016;31:2164\u201373.","journal-title":"Hum Reprod (Oxford, England)"},{"key":"4630_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1600-0897.2012.01178.x","volume":"68","author":"AR Han","year":"2012","unstructured":"Han AR, Ahn H, Vu P, Park JC, Gilman-Sachs A, Beaman K, et al. Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility. Am J Reprod Immunol. 2012;68:418\u201327.","journal-title":"Am J Reprod Immunol"},{"key":"4630_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0960-0760(93)90093-C","volume":"44","author":"RS Addison","year":"1993","unstructured":"Addison RS, Maguire DJ, Mortimer RH, Roberts MS, Cannell GR. Pathway and kinetics of prednisolone metabolism in the human placenta. J Steroid Biochem Mol Biol. 1993;44:315\u201320.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4630_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/aji.12373","volume":"74","author":"S Dan","year":"2015","unstructured":"Dan S, Wei W, Yichao S, Hongbo C, Shenmin Y, Jiaxiong W, et al. Effect of prednisolone administration on patients with unexplained recurrent miscarriage and in routine intracytoplasmic sperm injection: a meta-analysis. Am J Reprod Immunol. 2015;74:89\u201397.","journal-title":"Am J Reprod Immunol"},{"key":"4630_CR14","doi-asserted-by":"crossref","unstructured":"Ryu RJ, Easterling TR, Caritis SN, Venkataramanan R, Umans JG, Ahmed MS, et al. Prednisone pharmacokinetics during pregnancy and lactation. J Clin Pharmacol. 2018.","DOI":"10.1002\/jcph.1122"},{"key":"4630_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.fertnstert.2018.05.009","volume":"110","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2018","unstructured":"Practice Committee of the American Society for Reproductive Medicine. The role of immunotherapy in in vitro fertilization: a guideline. Fertil Steril. 2018;110:387\u2013400.","journal-title":"Fertil Steril"},{"key":"4630_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/humupd\/dmt032","volume":"19","author":"N Potdar","year":"2013","unstructured":"Potdar N, Gelbaya TA, Konje JC, Nardo LG. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2013;19:674\u201384.","journal-title":"Hum Reprod Update"},{"key":"4630_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/09513590.2017.1380182","volume":"34","author":"C Siristatidis","year":"2018","unstructured":"Siristatidis C, Dafopoulos K, El-Khayat W, Salamalekis G, Anifandis G, Vrantza T, et al. Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study. Gynecol Endocrinol. 2018;34:136\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"4630_CR18","doi-asserted-by":"publisher","unstructured":"Nastri CO, Lensen SF, Gibreel A, Raine-Fenning N, Ferriani RA, Bhattacharya S, et al. Endometrial injury in women undergoing assisted reproductive techniques. Cochrane Database Syst Rev. 2015:Cd009517. https:\/\/doi.org\/10.1002\/14651858.CD009517.pub3.","DOI":"10.1002\/14651858.CD009517.pub3"},{"key":"4630_CR19","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/S0140-6736(16)00258-0","volume":"387","author":"T El-Toukhy","year":"2016","unstructured":"El-Toukhy T, Campo R, Khalaf Y, Tabanelli C, Gianaroli L, Gordts SS, et al. Hysteroscopy in recurrent in-vitro fertilisation failure (TROPHY): a multicentre, randomised controlled trial. Lancet (London, England). 2016;387:2614\u201321.","journal-title":"Lancet (London, England)"},{"key":"4630_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/aji.12559","volume":"76","author":"J Fan","year":"2016","unstructured":"Fan J, Zhong Y, Chen C. Combined treatment of prednisone and aspirin, starting before ovulation induction, may improve reproductive outcomes in ANA-positive patients. Am J Reprod Immunol. 2016;76:391\u20135.","journal-title":"Am J Reprod Immunol"},{"key":"4630_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00404-013-3020-8","volume":"289","author":"M Fawzy","year":"2014","unstructured":"Fawzy M, El-Refaeey AA. Does combined prednisolone and low molecular weight heparin have a role in unexplained implantation failure? Arch Gynecol Obstet. 2014;289:677\u201380.","journal-title":"Arch Gynecol Obstet"},{"key":"4630_CR22","doi-asserted-by":"publisher","unstructured":"Nastri CO, Teixeira DM, Moroni RM, Navarro PA, Ferriani RA, Martins WP. Interventions for improving reproductive outcomes in women with recurrent implantation failure undergoing assisted reproductive techniques. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.CD010795.","DOI":"10.1002\/14651858.CD010795"},{"key":"4630_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00228-006-0169-0","volume":"62","author":"T Forges","year":"2006","unstructured":"Forges T, Monnier-Barbarino P, Guillet-May F, Faure GC, Bene MC. Corticosteroids in patients with antiovarian antibodies undergoing in vitro fertilization: a prospective pilot study. Eur J Clin Pharmacol. 2006;62:699\u2013705.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04630-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-020-04630-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04630-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:23:36Z","timestamp":1629159816000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-04630-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4630"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-04630-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"1 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol has been approved by the Ethics Committee at Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University (2018-073). Any important changes to the protocol will require a protocol amendment and must be approved by the Ethics Committee before implementation. Informed consent will be obtained from all participants prior to enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"719"}}